NSCLC STAGE IV
Clinical trials for NSCLC STAGE IV explained in plain language.
Never miss a new study
Get alerted when new NSCLC STAGE IV trials appear
Sign up with your email to follow new studies for NSCLC STAGE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy for tough lung cancer cases shows promise in early trial
Disease control TerminatedThis study tested a combination of the immunotherapy drug atezolizumab and a single low dose of radiation in 12 adults with advanced lung cancer (stage IV) whose disease had worsened after both chemotherapy and another type of immunotherapy. The goal was to see if this approach c…
Matched conditions: NSCLC STAGE IV
Phase: PHASE2 • Sponsor: Oncology Institute of Southern Switzerland • Aim: Disease control
Last updated May 26, 2026 05:02 UTC
-
Lung cancer drug trial halted early: what we know
Disease control TerminatedThis early-stage trial tested an experimental drug called MYTX-011 in people with advanced non-small cell lung cancer (NSCLC) that had spread or come back after standard treatments. The drug is an antibody-drug conjugate designed to deliver a powerful chemotherapy directly to can…
Matched conditions: NSCLC STAGE IV
Phase: PHASE1 • Sponsor: Mythic Therapeutics • Aim: Disease control
Last updated May 22, 2026 13:50 UTC